Get complete access to comprehensive company data for Solara Active Pharma Sciences Limited.
Complete Report
One-time • Full access
Credit Plan
Pay as you go • Instant
Processing your request...
Downloading your report...
Success
Request Company Screening
Solara Active Pharma Sciences Limited
Once your screening request is processed, you will receive a notification and the complete report will be available in PDF format for download from your account dashboard.
₹ 120.00 cr
₹ 40.25 cr
23 Feb 2017
31 Mar 2024
Solara Active Pharma Sciences Limited is an Indian public limited company incorporated on 23 Feb 2017. The company's registered office is situated in Thane, Maharashtra, India.
The current status of Solara Active Pharma Sciences Limited is Active. The company has filed its annual returns and financial statements up to 31 Mar 2024 (FY 2023-2024).
Solara Active Pharma Sciences Limited is a company limited by shares with an authorized capital of ₹120.00 cr and a paid-up capital of ₹40.25 cr as per the records maintained by the Ministry of Corporate Affairs (MCA).
Solara Active Pharma Sciences Limited has 9 directors and 3 signatories. The Key Managerial Personnel (KMP) at Solara Active Pharma Sciences Limited include Poorvank Purohit as Ceo, Arun Kumar Baskaran as CFO and Suddapalli Muralikrishna as Company Secretary. The directors of the company include Kausalya Santhanam, Ramakrishnan Rajagopal, Rajendra Kumar Srivastava, Kartheek Chintalapati Raju.
The registered office of Solara Active Pharma Sciences Limited is located at 201, Devavrata, Sector 17, Vashi, Navi Mumbai Maharashtra 400703 India in Thane, Maharashtra, India.
- CIN/LLPIN/FCRN: L24230MH2017PLC291636
- Legal Name: Solara Active Pharma Sciences Limited
- ROC Code: Roc Mumbai
- Company No.: 291636
- Company Category: Company Limited By Shares
- Company Sub Category: Non-Government Company
- Company Class: Public
- Listing Status: Listed
- Industry: Pharma
- Date of AGM: 20 Sep 2024
🔒 14.3%
(FY 202_)🔒 8.9%
(FY 202_)🔒 12.7%
(FY 202_)🔒 9.5%
(FY 202_)🔒 11.8%
(FY 202_)🔒 15.2%
(FY 202_)🔒 10.6%
(FY 202_)🔒 13.4%
(FY 202_)
Financial Performance Overview
| Financial Metric | FY 2023 | Growth | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | 12,45,67,890 | +191.42% | 4,26,78,123 | 3,89,45,234 | 2,98,12,456 | 2,15,67,890 |
| Revenue from Operations | 11,98,45,678 | +176.82% | 4,32,10,987 | 3,78,90,123 | 2,89,45,678 | 2,10,23,456 |
| Total Assets | 45,67,89,012 | +61.07% | 28,34,56,789 | 24,56,78,901 | 19,87,65,432 | 16,54,32,109 |
| Profit or Loss | -1,23,45,678 | 24.56% | 4,32,109 | 2,15,678 | 1,89,234 | 1,23,456 |
| Net Worth | 12,34,56,789 | 85.66% | 85,67,89,012 | 78,90,12,345 | 65,43,21,098 | 54,32,10,987 |
| EBITDA | 2,34,56,789 | +6604.87% | 3,49,012 | 2,10,987 | 1,56,789 | 98,765 |
| Past Director Details of Solara Active Pharma Sciences Limited |
|---|
Frequently Asked Questions
- arun kumar baskaran
- arun kumar pillai
- kartheek chintalapati raju
- kausalya santhanam
- manish gupta
- mohan muthunarayanan
- poorvank purohit
- poorvank purohit
- rajendra kumar srivastava
- rajiv vijay nabar
- ramakrishnan rajagopal
- suddapalli muralikrishna